News

Keep up to date with us.

Live Webinar: The Role of Next-Gen NITs in NAFLD/NASH

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on The Role of Next-Gen Non-Invasive Tests (NITs) in NAFLD/NASH.

Join presenter Dr. Robert Gish, a renowned hepatologist and gastroenterologist, to learn about:

  • Non-Invasive Tests (NITs) for Detecting NAFLD/NASH
  • Role of NITs in Staging Fibrosis & Quantifying Steatosis
  • Best Practices for Integrating NITs into Practice

Date & Time:

March 17, 2021, 9AM to 10AM PT

Register Now

 

Speaker Bio

Dr. Robert Gish is a fellow of the American Association for the Study of Liver Disease, the American Society of Transplantation and American College of Physicians. He was a major early contributor to decipher methods for the detection of hepatitis B and C virus and characterizing their epidemiology and clinical presentation in humans. Dr. Gish is currently an Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno. He serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, a Clinical Professor of Medicine at Loma Linda University as well as a Staff Physician at Loma Linda University’s Liver Transplant Clinic in Las Vegas. In addition, he is also Medical Director of the Asia Pacific Health Foundation in San Diego, CA and of the Hepatitis B Foundation in Doylestown, Pennsylvania. Dr. Gish is currently seeing patients, both in-person and via telemedicine, at various clinics including, Telemed2U, San Diego, Folsom, San Jose, Santa Rosa and Las Vegas/Reno.

Sonic Incytes Medical Corp.

Sonic Incytes believes in creating accessible and affordable diagnostic solutions – with health insights you can count on – to improve patient care. Recognizing the rise of chronic liver disease, Sonic Incytes has made it its mission to reduce the disease by enabling routine assessment and improved management of liver health. Its breakthrough, point of care ultrasound solution, VelacurTM, is redefining the standard of care in quantifying chronic liver disease – with diagnostic accuracy comparable to MRI.

Follow us on LinkedInTwitterYouTube and www.sonicincytes.com.